Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Suppression of lymphocyte responses by tuberculous plasma and mycobacterial arabinogalactan. Monocyte dependence and indomethacin reversibility.
M E Kleinhenz, … , P J Spagnuolo, T M Daniel
M E Kleinhenz, … , P J Spagnuolo, T M Daniel
Published July 1, 1981
Citation Information: J Clin Invest. 1981;68(1):153-162. https://doi.org/10.1172/JCI110231.
View: Text | PDF
Research Article

Suppression of lymphocyte responses by tuberculous plasma and mycobacterial arabinogalactan. Monocyte dependence and indomethacin reversibility.

  • Text
  • PDF
Abstract

During tuberculosis, exposure of monocytes to circulating factors may induce the suppressor activity observed in some anergic patients. To explore this possibility, we examined the effects of plasma pooled from 28 untreated tuberculosis (TB) patients and the mycobacterial cell wall polysaccharide D-arabino-D-galactan (AG) on the in vitro function of peripheral blood mononuclear cells (PBMC) from healthy donors. In the [3H] thymidine incorporation assay, stimulated responses of PBMC incubated in culture medium supplemented with TB plasma or co-cultured with 3.0 microgram/ml AG were depressed significantly when compared with control responses. Cytotoxicity and altered kinetics of stimulated DNA synthesis did not contribute to the observed suppression. TB plasma and AG-induced suppression of the PBMC response to purified protein derivative was monocyte dependent and indomethacin reversible. In addition, TB plasma and AG directly inhibited the phytohemagglutinin-stimulated responses of T lymphocytes. In a quantitative assay of monocyte attachment to plastic, both TB plasma and AG significantly increased monocyte adherence from basal levels. These effects on monocyte adherence were reversed with indomethacin or antibody to mycobacterial polysaccharide. In addition, TB plasma passed over an immunoabsorbent column of Sepharose-linked antibody to mycobacterial polysaccharide was depleted of the suppressive and monocyte-adherence augmenting factors. 3.0 microgram/ml AG stimulated a fivefold increase in prostaglandin E2 production by cultured mononuclear cells. Our data suggest that AG circulating alone or bound in immune complexes may account for the observed effects of TB plasma. Similar in vivo exposure may contribute to the cell-mediated suppression of lymphocyte responses in tuberculosis.

Authors

M E Kleinhenz, J J Ellner, P J Spagnuolo, T M Daniel

×

Total citations by year

Year: 2024 2022 2011 2008 2007 2005 2004 2002 2001 1999 1997 1996 1995 1994 1993 1992 1991 1990 1989 1988 1987 1986 1985 1984 1983 1982 Total
Citations: 1 1 1 3 1 1 1 2 1 1 2 1 1 1 4 3 4 2 2 5 5 1 6 3 4 2 59
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (59)

Title and authors Publication Year
Differences in PPD- and mitogen-induced T-cell activation marker expression characterize immunopathology in acute tuberculosis patients.
Acheampong I, Minadzi D, Laing EF, Frimpong M, Vivekanandan MM, Yeboah A, Adankwah E, Aniagyei W, Arthur JF, Lamptey M, Abass MK, Kumbel F, Osei-Yeboah F, Gawusu A, Debrah LB, Owusu DO, Debrah A, Mayatepek E, Seyfarth J, Phillips RO, Jacobsen M
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 2024
Arabinogalactan enhances Mycobacterium marinum virulence by suppressing host innate immune responses.
Li YY, Liu HM, Wang D, Lu Y, Ding C, Zhou LS, Wu XY, Zhou ZW, Xu SQ, Lin C, Qin LH, Li Y, Liu J, Liu HP, Zhang L
Frontiers in immunology 2022
Differential Expression of MicroRNA and Predicted Targets in Pulmonary Sarcoidosis
ED Crouser, MW Julian, M Crawford, G Shao, L Yu, SR Planck, JT Rosenbaum, SP Nana-Sinkam
Biochemical and Biophysical Research Communications 2011
In vitro production of tumour necrosis factor and prostaglandin E2 by peripheral blood mononuclear cells from tuberculosis patients
J Cadranel, C Philippe, J Perez, B Milleron, G Akoun, R Ardaillou, L Baud
Clinical & Experimental Immunology 2008
Generation and function of human regulatory CD8+ T cells induced by a humanized OKT3 monoclonal antibody hOKT3γ1(Ala-Ala)
V Ablamunits, KC Herold
Human Immunology 2008
Clinical Tuberculosis 4th Edition
S Lucas
Clinical Tuberculosis 4th Edition 2008
Tuberculosis
G Maartens, RJ Wilkinson
The Lancet 2007
Structural elucidation of the predominant motifs of the major cell wall arabinogalactan antigens from the borderline species Tsukamurella paurometabolum and Mycobacterium fallax
M Tropis, A Lemassu, V Vincent, M Daffé
Glycobiology 2005
Gamma Interferon Production by Bovine γδ T Cells following Stimulation with Mycobacterial Mycolylarabinogalactan Peptidoglycan
B Vesosky, OC Turner, J Turner, IM Orme
Infection and immunity 2004
Glycomicrobiology
RJ Doyle
2002
Evidence for prostaglandin-producing supressor cells in HCV patients with normal ALT
Rui Marinho, Ruth Pinto, Maria Livia Santos, MouraMiguelCarneiro de
Digestive Diseases and Sciences 2002
Advances in Microbial Physiology
IC Blomfield
Advances in Microbial Physiology Volume 45 2001
A man with multiple infections with unusual organisms
M Mates, CH Kirkpatrick
Annals of Allergy Asthma & Immunology 1999
Examining a paradox in the pathogenesis of human pulmonary tuberculosis: Immune activation and suppression/anergy
G Vanham, Z Toossi, CS Hirsch, RS Wallis, SK Schwander, EA Rich, JJ Ellner
Tubercle and Lung Disease 1997
Altered expression of Fc gammaRIII (CD16) on polymorphonuclear neutrophils from individuals with human immunodeficiency virus type 1 disease and pulmonary tuberculosis
S Meddows-Taylor, DJ Martin, CT Tiemessen
Clinical and diagnostic laboratory immunology 1997
Structure de l'enveloppe de Mycobacterium tuberculosis
M Daffé
Médecine et Maladies Infectieuses 1996
Characterization of an Inhibitory Seric Factor From Tuberculosis Anergic Patients That Acts on non-Adherent PPD Reactive Cells
ML Taylor, N Elizondo, H Mejia-López, J Casasola, LG Martinez-garcia, E Zenteno, MA Salazar, M Selman
Immunological Investigations 1995
Treatment and developmental therapeutics of Mycobacterium avium complex (MAC) infections
VS Georgiev
International Journal of Antimicrobial Agents 1994
Intracellular levels and extracellular release of lysosomal enzymes from peripheral blood monocytes in pulmonary tuberculosis patients
S Jaswal, R Dhand, AK Sethi, KK Kohli, NK Ganguly
APMIS 1993
Immunoregulatory biological response modifiers: effect of cytokines on septic shock
MA Chirigos, CD Simone
Mediators of Inflammation 1993
Immunological responses in patients with tuberculosis and in vivo effects of acetyl-L-carnitine oral administration
E Jirillo, M Altamura, C Marcuccio, C Tortorella, CD Simone, S Antonaci
Mediators of Inflammation 1993
Mycobacterial antigen complex A60-specific T-cell repertoire during the course of pulmonary tuberculosis
S Carlucci, A Beschin, L Tuosto, F Ameglio, GM Gandolfo, C Cocito, F Fiorucci, C Saltini, E Piccolella
Infection and immunity 1993
Is Prophylactic Immunostimulation of the Host against Pathogenic Microbial Antigens an Adequate Strategy of Immunoprotection?
MP Arala-Chaves
Scandinavian Journal of Immunology 1992
Detection of lipoarabinomannan as a diagnostic test for tuberculosis
E Sada, D Aguilar, M Torres, T Herrera
Journal of clinical microbiology 1992
The immunopathology of systemic anergy in infectious diseases: A reappraisal and new perspectives
NE Bianco
Clinical Immunology and Immunopathology 1992
Antigens of the Mycobacterium avium, Micobacterium intracellulare complex
SL Morris
European Journal of Epidemiology 1991
Growth ofMycobacterium avium in human monocytes: identification of cytokines which reduce and enhance intracellular microbial growth
M Denis
European Journal of Immunology 1991
Effects of Acetyl-L-Carnitine Oral Administration on Lymphocyte Antibacterial Activity and TNF-α Levels in Patients with Active Pulmonary Tuberculosis. A Randomized Double Blind Versus Placebo Study
E Jirillo, M Altamura, I Munno, NM Pellegrino, R Sabato, SD Fabio, CD Simone
Immunopharmacology and Immunotoxicology 1991
Indomethacin-sensitive monocyte killing defect in a child with disseminated atypical mycobacterial disease
D Ridgway, LJ Wolff, M Wall, MS Borzy, CH Kirkpatrick
Journal of Clinical Immunology 1991
Predominant structural features of the cell wall arabinogalactan of Mycobacterium tuberculosis as revealed through characterization of oligoglycosyl alditol fragments by gas chromatography/mass spectrometry and by 1H and 13C NMR analyses
M Daffe, PJ Brennan, M McNeil
The Journal of biological chemistry 1990
In vitro production of tumour necrosis factor and prostaglandin E2 by peripheral blood mononuclear cells from tuberculosis patients.
Cadranel J, Philippe C, Perez J, Milleron B, Akoun G, Ardaillou R, Baud L
Clinical & Experimental Immunology 1990
Identification of antigens of Mycobacterium tuberculosis using human monoclonal antibodies
RS Wallis, SL Alde, DV Havlir, MH Amir-Tahmasseb, TM Daniel, JJ Ellner
Journal of Clinical Investigation 1989
Induction of Non-Specific Immunosuppression in Mice by Mycobacterial Infections and Its Relationship to Macrophage Activation
R Appelberg, R Soares, P Ferreira, MT Silva
Scandinavian Journal of Immunology 1989
Leprosy
RC Hastings, TP Gillis, JL Krahenbuhl, SG Franzblau
Clinical microbiology reviews 1988
Progressive cellular immune impairment leading to development of AIDS: two-year prospective study of HIV infection in drug addicts
E Fernandez-Cruz, AM Fernandez, C Gutierrez, M Garcia-Montes, MT de la Morena, J Rodriguez-Villanueva, N Longo, JM Zabay
Clinical & Experimental Immunology 1988
Primary tuberculous liver abscess associated with the human immunoderciency virus
JJ Weinberg, P Cohen, R Malhotra
Tubercle 1988
Immune status in tuberculosis and response to treatment
JK Onwubalili, GM Scott
Tubercle 1988
Mycobacterium tuberculosis
M Bendinelli, H Friedman
1988
Immunologic dysfunction in the pathogenesis of periodontal diseases*
BJ Shenker
Journal of Clinical Periodontology 1987
Immunosuppressive effects of Centipeda periodontii: selective cytotoxicity for lymphocytes and monocytes
BJ Shenker, P Berthold, P Dougherty, KK Porter
Infection and immunity 1987
Characterization of a factor in leprosy serum that inhibits the growth of mitogen-stimulated normal human lymphocytes
MA Kerr, YM Hussein, RC Potts, JS Beck, MM Sheriff
Immunology 1987
The mechanism of action of the factor in leprosy serum that inhibits the growth of mitogen-stimulated normal human lymphocytes
YM Hussein, MA Kerr, JS Beck
Immunology 1987
Effect of serum on lymphocyte blastogenesis
O Barta, LJ Huang, SS Pourciau, LM Shaffer
Veterinary Immunology and Immunopathology 1987
Interleukin-1 Production by Blood Monocytes and Bronchoalveolar Cells in Sarcoidosis
ME Kleinhenz, H Fujiwara, EA Rich
Annals of the New York Academy of Sciences 1986
Mycobacterial disease—a challenge to biotechnology
JM Grange
Mircen Journal of Applied Microbiology and Biotechnology 1985
Deficient immune interferon production in tuberculosis
JK Onwubalili, GM Scott, JA Robinson
Clinical & Experimental Immunology 1985
Suppression of lymphocyte proliferation by Pseudomonas aeruginosa: mediation by Pseudomonas-activated suppressor monocytes
TB Issekutz, JM Stoltz
Infection and immunity 1985
Immunologic Effects of Nonsteroidal Anti-inflammatory Agents
JS Goodwin
Medical Clinics of North America 1985
Granulomatous involvement of the liver in patients with AIDS
MS Orenstein, A Tavitian, B Yonk, HP Dincsoy, J Zerega, SK Iyer, EW Straus
Gut 1985
Prostaglandins and Immunity
JS Goodwin
1985
Identification of a specific interleukin 1 inhibitor in the urine of febrile patients
Z Liao, RS Grimshaw, DL Rosenstreich
Journal of Experimental Medicine 1984
Immunologic Effects of Nonsteroidal Anti-Inflammatory Drugs
JS Goodwin
The American Journal of Medicine 1984
Modulation of immunologic responses in nontuberculous mycobacterial infections with indomethacin
UG Mason, CH Kirkpatrick
Journal of Clinical Immunology 1984
Regulation of the immune response by prostaglandins
JS Goodwin, J Ceuppens
Journal of Clinical Immunology 1983
Suppression of in vitro lymphocyte DNA synthesis by killed Pseudomonas aeruginosa
HR Rubin, RU Sorensen, PA Chase, JD Klinger
Infection and immunity 1983
Difference in effect of single immunosuppressive agents (cyclophosphamide, CCNU, 5-FU) on peripheral blood immune cell parameters and central nervous system immunoglobulin synthesis rate in patients with multiple sclerosis
WW Shih, RW Baumhefner, WW Tourtellotte, CM Haskell, EL Korn, JL Fahey
Clinical & Experimental Immunology 1983
Immunology of human schistosomiasis
JJ Ellner
Clinical Immunology Newsletter 1983
Indomethacin-responsive mononuclear cell dysfunction in “atypical” mycobacteriosis
UG Mason, LE Greenberg, SS Yen, CH Kirkpatrick
Cellular Immunology 1982
Mycobacterium fortuitum infection: Evidence of bactericidal defect due to hyperactive antigen-specific suppressor cells
JD Gardner, M Ousley, W Godfrey, NJ Linds, NI Abdou
The American Journal of Medicine 1982

← Previous 1 2 3 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts